Seminars in Diagnostic Pathology
Volume 23, Issue 3 , Pages 170-181 , August 2006

Transplantation pathology

  • Stefan G. Hübscher, MD

      Affiliations

    • Corresponding Author InformationAddress reprint requests and correspondence: Stefan G. Hübscher, MD, Department of Pathology, University of Birmingham, Birmingham B15 2TT, United Kingdom.

References 

  1. Hubscher SG, Portmann BC. Transplantation pathology. In:  Burt AD,  Portmann BC,  Ferrell LD editor. MacSween’s Pathology of the Liver. Edinburgh: Churchill Livingstone; 2006;p. 815–879
  2. Tran TT, Changsri C, Shackleton CR, et al. Living donor liver transplantation: histological abnormalities found on liver biopsies of apparently healthy potential donors. J Gastroenterol Hepatol. 2006;21:381–383
  3. Pungpapong S, Krishna M, Abraham SC, et al. Clinicopathologic findings and outcomes of liver transplantation using grafts from donors with unrecognized and unusual diseases. Liver Transpl. 2006;12:310–315
  4. Usuda M, Fujimori K, Koyamada N, et al. Successful use of anti-CD20 monoclonal antibody (rituximab) for ABO-incompatible living-related liver transplantation. Transplantation. 2005;79:12–16
  5. Haga H, Egawa H, Fujimoto Y, et al. Acute humoral rejection and C4d immunostaining in ABO blood type-incompatible liver transplantation. Liver Transpl. 2006;12:457–464
  6. Dankof A, Schmeding M, Morawietz L, et al. Portal capillary C4d deposits and increased infiltration by macrophages indicate humorally mediated mechanisms in acute cellular liver allograft rejection. Virchows Arch. 2005;447:87–93
  7. Schmeding M, Dankof A, Krenn V, et al. C4d in acute rejection after liver transplantation: a valuable tool in differential diagnosis to hepatitis C recurrence. Am J Transplant. 2006;6:523–530
  8. Neuman UP, Neuhaus PC. C4d immunostaining in acute humoral rejection after ABO blood group-incompatible liver transplantation. Liver Transpl. 2006;12:356–357
  9. Demetris AJ, Adeyi O, Bellamy CO, et al. Liver biopsy interpretation for causes of late liver allograft dysfunction. Hepatology. 2006;44:489–501
  10. Sundaram SS, Melin-Aldana H, Neighbors K, et al. Histologic characteristics of late cellular rejection, significance of centrilobular injury, and long-term outcome in pediatric liver transplant recipients. Liver Transpl. 2006;12:58–64
  11. International Panel. Banff schema for grading liver allograft rejection: an international consensus document. Hepatology. 1997;25:658–663
  12. Demetris A, Adams D, Bellamy C, et al. An International Panel Update of the International Banff Schema for Liver Allograft Rejection: working recommendations for the histopathologic staging and reporting of chronic rejection. Hepatology. 2000;31:792–799
  13. Demetris AJ, Kelly DM, Eghtesad B, et al. Pathophysiologic observations and histopathologic recognition of the portal hyperperfusion or small-for-size syndrome. Am J Surg Pathol. 2006;30:986–993
  14. Krishna M, Keaveny AP, Genco PV, et al. Clinicopathological review of 18 cases of liver allografts lost due to bile duct necrosis. Transplant Proc. 2005;37:2221–2223
  15. Hubscher SG. Recurrent and de-novo disease in the liver allograft. Curr Opin Organ Transplant. 2006;11:283–288
  16. Demetris AJ, Eghtesad B, Marcos A, et al. Recurrent hepatitis C in liver allografts: prospective assessment of diagnostic accuracy, identification of pitfalls, and observations about pathogenesis. Am J Surg Pathol. 2004;28:658–669
  17. Regev A, Molina E, Moura R, et al. Reliability of histopathologic assessment for the differentiation of recurrent hepatitis C from acute rejection after liver transplantation. Liver Transpl. 2004;10:1233–1239
  18. Riva S, Sonzogni A, Bravi M, et al. Late graft dysfunction and autoantibodies after liver transplantation in children: preliminary results of an Italian experience. Liver Transpl. 2006;12:573–577
  19. Neuberger J. Chronic allograft dysfunction: diagnosis and management (Is it always progressive?). Liver Transpl. 2005;11:S63–S68
  20. Evans HM, Kelly DA, McKiernan PJ, et al. Progressive histological damage in liver allografts following pediatric liver transplantation. Hepatology. 2006;43:1109–1117

PII: S0740-2570(06)00173-0

doi: 10.1053/j.semdp.2006.11.004

Seminars in Diagnostic Pathology
Volume 23, Issue 3 , Pages 170-181 , August 2006

Article Tools

* Image Usage & Resolution